Erasca, Inc. (ERAS) stock
ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$13.89−1.22 (-8.07%)
Close on Nov 17, 2026Market cap $4.86BP/E –Yield 0.00%
Erasca EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Erasca
Erasca has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?